microRNAs and cancer: role in tumorigenesis, patient classification and therapy
暂无分享,去创建一个
[1] John Bracht,et al. MicroRNAs: a developing story. , 2005, Current opinion in genetics & development.
[2] W. S. Hayward,et al. Avian bic, a Gene Isolated from a Common Retroviral Site in Avian Leukosis Virus-Induced Lymphomas That Encodes a Noncoding RNA, Cooperates with c-myc in Lymphomagenesis and Erythroleukemogenesis , 2002, Journal of Virology.
[3] H. Vornlocher,et al. Inhibition of bcr-abl gene expression by small interfering RNA sensitizes for imatinib mesylate (STI571). , 2003, Blood.
[4] C. Croce,et al. A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[5] R. Bernards,et al. Stable suppression of tumorigenicity by virus-mediated RNA interference. , 2002, Cancer cell.
[6] Yang Shi,et al. Small RNA: can RNA interference be exploited for therapy? , 2003, The Lancet.
[7] F. Buchholz,et al. RNA interference: gene silencing in the fast lane. , 2003, Seminars in cancer biology.
[8] Shuta Tomida,et al. Reduced expression of Dicer associated with poor prognosis in lung cancer patients , 2005, Cancer science.
[9] U. Zangemeister‐Wittke. Antisense to Apoptosis Inhibitors Facilitates Chemotherapy and TRAIL‐Induced Death Signaling , 2003, Annals of the New York Academy of Sciences.
[10] G. Stamatoyannopoulos,et al. Down-regulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in vitro. , 2003, Cancer research.
[11] H. Horvitz,et al. MicroRNA expression profiles classify human cancers , 2005, Nature.
[12] A. Harel-Bellan,et al. SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth. , 2003, Cancer research.
[13] C. Croce,et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[14] V. Ambros. The functions of animal microRNAs , 2004, Nature.
[15] B. Harfe,et al. MicroRNAs in vertebrate development. , 2005, Current opinion in genetics & development.
[16] Ravi Sachidanandam,et al. A germline-specific class of small RNAs binds mammalian Piwi proteins , 2006, Nature.
[17] Annick Harel-Bellan,et al. Synthetic small inhibiting RNAs: Efficient tools to inactivate oncogenic mutations and restore p53 pathways , 2002 .
[18] Peter A. Jones,et al. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. , 2006, Cancer cell.
[19] Tushar Patel,et al. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. , 2006, Gastroenterology.
[20] R. Stephens,et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. , 2006, Cancer cell.
[21] H. Liber,et al. Silencing expression of the catalytic subunit of DNA-dependent protein kinase by small interfering RNA sensitizes human cells for radiation-induced chromosome damage, cell killing, and mutation. , 2002, Cancer research.
[22] R. Schiffelers,et al. Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. , 2004, Nucleic acids research.
[23] S. Raguz,et al. Complete reversal of multidrug resistance by stable expression of small interfering RNAs targeting MDR1 , 2004, Gene Therapy.
[24] Tara L. Naylor,et al. microRNAs exhibit high frequency genomic alterations in human cancer. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[25] Muller Fabbri,et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. , 2005, The New England journal of medicine.
[26] A. Borkhardt,et al. Silencing of disease-related genes by small interfering RNAs. , 2004, Current molecular medicine.
[27] D. Bartel. MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.
[28] Kathryn A. O’Donnell,et al. c-Myc-regulated microRNAs modulate E2F1 expression , 2005, Nature.
[29] M. Woodle,et al. siRNA-mediated antitumorigenesis for drug target validation and therapeutics. , 2003, Current opinion in molecular therapeutics.
[30] G. Hannon,et al. Unlocking the potential of the human genome with RNA interference , 2004, Nature.
[31] C. Benz,et al. Rapid alteration of microRNA levels by histone deacetylase inhibition. , 2006, Cancer research.
[32] A. Ganser,et al. Stable RNA interference (RNAi) as an option for anti-bcr-abl therapy , 2005, Gene Therapy.
[33] Y. Yuzawa,et al. A Small Interfering RNA Targeting Vascular Endothelial Growth Factor as Cancer Therapeutics , 2004, Cancer Research.
[34] Y. Yatabe,et al. Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival , 2004, Cancer Research.
[35] C. Croce,et al. MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.
[36] N. Rajewsky. microRNA target predictions in animals , 2006, Nature Genetics.
[37] N. Lau,et al. Characterization of the piRNA Complex from Rat Testes , 2006, Science.
[38] S. Uprichard. The therapeutic potential of RNA interference , 2005, FEBS Letters.
[39] S. Lowe,et al. A microRNA polycistron as a potential human oncogene , 2005, Nature.
[40] D. Bartel,et al. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs , 2004, Nature Reviews Genetics.